Brawn Biotech Ltd — Board Meeting, 13-08-2025: Board Meeting

Brawn Biotech has announced that its Board of Directors approved the financial results for the quarter. The company reported a total revenue of 5.89 Cr, up from 4.06 Cr in the same quarter last year. Significantly, the company turned a profit of 0.24 Cr for the period, a positive shift compared to a loss of 0.53 Cr in the prior year's corresponding quarter. Basic earnings per share stood at 0.89. This update provides investors with a clear picture of the company's improved financial performance.